CS Genetics · 6 days ago
VP of Enterprise Programs
Pleasanton, CA
Full-time
Onsite
Director/Executive
10+ years expCS Genetics is seeking a VP of Enterprise Programs to establish and scale enterprise programs across pharma and research organizations. This role involves owning strategic accounts and ensuring the integration of CS Genetics' platform into complex screening workflows.
BiotechnologyHealth CareLife Science
Responsibilities
Own and execute enterprise programs with top-tier pharma and pharma-scale research organizations
Lead deals from initial engagement through pilot, program expansion, and platform-level adoption
Serve as the primary commercial owner of long-cycle, high-complexity enterprise relationships
Design programs that embed CS Genetics’ single-cell platform and Navigator decision layer into post-HTS, secondary screening, and MoA workflows
Translate scientific value into clear program structure: scope, success criteria, decision points, and expansion paths
Shape how customers operationalize SimpleCell and Navigator as part of their existing screening cascades
Act as the front-line signal for product–market fit, feeding concrete customer insight back into product, pricing, and roadmap decisions
Partner with marketing to refine positioning, use-case definition, and program narratives based on real adoption patterns
Help define what 'enterprise readiness' means across scientific, operational, and commercial dimensions
Work closely with the CEO, CMO, and technical leadership to align commercial strategy with platform capabilities
Help define future commercial roles, handoffs, and structure as the enterprise motion matures
Operate without a sales team initially, setting the foundation for future scale
Qualification
Required
10+ years of experience selling, building, or operating enterprise programs in pharma or pharma-adjacent environments
Deep familiarity with high-throughput screening (HTS), secondary screening, MoA studies, or related discovery workflows
Proven ability to navigate complex buying groups (scientific, translational, informatics, and platform stakeholders)
Track record of closing and expanding high-value, long-cycle enterprise engagements
Comfort operating independently in ambiguous, early-stage environments without a predefined playbook
Strong working knowledge of drug discovery workflows and decision-making processes
Broad familiarity with transcriptomics, omics, or advanced screening readouts; single-cell expertise is helpful but not required
Ability to engage credibly with senior scientific and translational leaders
Preferred
Experience selling platforms, workflows, or decision-support systems (not just tools or consumables)
Company
CS Genetics
CS Genetics develops new technology for genomics, based on scientific insights and conceptual innovations in NGS techniques.
11-50 employees
Funding
Current Stage
Early StageTotal Funding
$2.23M2021-06-10Debt Financing· $2.23M
Leadership Team
Bill Colston
CEO
Jeremy Preston
Chief Executive Officer
Recent News
2025-09-17
MarketsandMarkets Research Pvt. Ltd.
2025-08-21
Company data provided by crunchbase